Hana Must SPAC 2 Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Hana Must SPAC 2 cash flow conversion efficiency. Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hana Must SPAC 2 (2015–2024)

Cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hana Must SPAC 2 share price for real-time trading data and today's change.

Hana Must SPAC 2 Cash Flow Conversion Ratio Explained

Hana Must SPAC 2 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency. Also see Hana Must SPAC 2 market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cardlytics Inc NASDAQ:CDLX	1.409x
Townsquare Media Inc NYSE:TSQ	-0.040x
T&R Biofab Co. Ltd KQ:246710	0.002x
dMY Squared Technology Group Inc NYSE MKT:DMYY	1.695x
Ausquest Ltd AU:AQD	-0.031x
KB No.2 Special Purpose Acq KQ:192250	-0.002x
Vishnu Prakash R Punglia Limited NSE:VPRPL	0.089x
IBKS No2 SPAC KQ:204840	0.053x

Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)

The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. Review Hana Must SPAC 2 (208370) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩63.80 Billion ≈ $43.24 Million	₩4.50 Billion ≈ $3.05 Million	0.071x	+22.09%
2023-12-31	₩60.10 Billion ≈ $40.73 Million	₩3.47 Billion ≈ $2.35 Million	0.058x	+3640.27%
2022-12-31	₩32.89 Billion ≈ $22.29 Million	₩50.81 Million ≈ $34.43K	0.002x	-98.52%
2021-12-31	₩28.06 Billion ≈ $19.02 Million	₩2.93 Billion ≈ $1.98 Million	0.104x	-38.53%
2020-12-31	₩24.89 Billion ≈ $16.87 Million	₩4.23 Billion ≈ $2.86 Million	0.170x	+11.18%
2019-12-31	₩24.14 Billion ≈ $16.36 Million	₩3.69 Billion ≈ $2.50 Million	0.153x	+132.33%
2018-12-31	₩14.60 Billion ≈ $9.90 Million	₩-6.90 Billion ≈ $-4.67 Million	-0.472x	-205.32%
2017-12-31	₩27.81 Billion ≈ $18.85 Million	₩-4.30 Billion ≈ $-2.92 Million	-0.155x	+33.13%
2016-12-31	₩26.92 Billion ≈ $18.24 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.231x	-2788.35%
2015-12-31	₩19.09 Billion ≈ $12.94 Million	₩164.29 Million ≈ $111.33K	0.009x	--

About Hana Must SPAC 2

KQ:208370 Korea Medical Devices

Market Cap

$36.86 Million

₩54.39 Billion KRW

Market Cap Rank

#22827 Global

#1508 in Korea

Share Price

₩2115.00

Change (1 day)

+0.95%

52-Week Range

₩2095.00 - ₩6650.00

All Time High

₩12885.20